AS India witnesses a steady rise in cancer cases, with projections indicating a sharp increase in lung, breast, prostate and gastrointestinal cancers in the com ...
The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...
The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million ...
Good afternoon, and welcome to Vir Biotechnology's conference call to discuss the company's VIR-5500 Strategic Collaboration with Astellas and Positive Phase I Data, and 2025 financial results. As a ...
The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.
1hon MSN
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results